NPI: 1689625568 · EL DORADO, AR 71730 · General Acute Care Hospital · NPI assigned 05/15/2006
Authorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
| Authorized Official | LALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL) |
| NPI Enumeration Date | 05/15/2006 |
Other providers sharing the same authorized official: LALOR, PAULA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 46,845 | $675K |
| 2019 | 50,951 | $780K |
| 2020 | 40,912 | $687K |
| 2021 | 45,999 | $792K |
| 2022 | 49,627 | $920K |
| 2023 | 26,108 | $456K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 18,576 | 15,106 | $383K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2,960 | 1,275 | $291K |
| 70450 | Computed tomography, head or brain; without contrast material | 3,174 | 2,712 | $242K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,897 | 1,617 | $206K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3,772 | 3,068 | $202K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 5,952 | 5,096 | $188K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 5,824 | 1,496 | $172K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1,463 | 1,327 | $163K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 862 | 673 | $143K |
| 80048 | Basic metabolic panel (calcium, ionized) | 7,293 | 5,785 | $117K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 20,696 | 16,225 | $111K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 524 | 408 | $109K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 3,125 | 2,526 | $93K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,489 | 1,277 | $84K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,675 | 1,406 | $77K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 5,398 | 3,358 | $74K |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,537 | 2,917 | $63K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 9,152 | 7,042 | $60K |
| 87428 | 920 | 850 | $57K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,877 | 2,491 | $56K |
| 72125 | Computed tomography, cervical spine; without contrast material | 571 | 469 | $54K |
| 71045 | Radiologic examination, chest; single view | 7,238 | 5,922 | $49K |
| 81001 | 13,203 | 10,898 | $47K | |
| 84484 | 6,159 | 3,986 | $47K | |
| 80050 | General health panel | 976 | 961 | $46K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,107 | 1,033 | $45K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,795 | 1,439 | $43K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 291 | 243 | $41K |
| 80061 | Lipid panel | 4,338 | 3,731 | $38K |
| 71046 | Radiologic examination, chest; 2 views | 2,280 | 1,953 | $35K |
| 87430 | 3,117 | 2,819 | $34K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2,905 | 1,650 | $32K |
| 83880 | 2,103 | 1,708 | $31K | |
| 85027 | 5,004 | 4,172 | $31K | |
| 36415 | Collection of venous blood by venipuncture | 4,714 | 3,918 | $29K |
| 81025 | 4,005 | 3,536 | $28K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 2,411 | 2,008 | $28K |
| 87070 | 1,023 | 852 | $27K | |
| 97161 | 512 | 410 | $27K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 3,627 | 3,183 | $26K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 799 | 664 | $24K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,255 | 1,906 | $24K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2,141 | 1,763 | $23K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,149 | 3,580 | $22K |
| 87186 | 2,021 | 1,727 | $22K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3,258 | 2,830 | $22K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 511 | 427 | $21K |
| 82962 | 4,285 | 1,705 | $20K | |
| 82553 | 3,128 | 2,439 | $20K | |
| 86403 | 1,530 | 1,396 | $20K | |
| 86901 | 1,137 | 924 | $18K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 4,033 | 3,478 | $17K |
| 74018 | 902 | 784 | $17K | |
| 83735 | 4,078 | 3,208 | $17K | |
| 83690 | 3,248 | 2,754 | $16K | |
| 11043 | 114 | 72 | $15K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 200 | 180 | $15K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 3,255 | 2,738 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 914 | 805 | $14K |
| 87077 | 2,158 | 1,854 | $13K | |
| 83655 | 866 | 809 | $13K | |
| 82550 | 3,398 | 2,653 | $12K | |
| 87040 | 1,681 | 839 | $12K | |
| 84703 | 1,165 | 939 | $11K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 91 | 73 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,483 | 1,223 | $10K |
| 85610 | 2,414 | 1,952 | $8K | |
| 86850 | 747 | 611 | $8K | |
| 73221 | 46 | 40 | $8K | |
| 82150 | 1,733 | 1,516 | $8K | |
| 85730 | 1,602 | 1,302 | $8K | |
| 83874 | 1,155 | 1,004 | $8K | |
| 84439 | 1,355 | 1,212 | $8K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 199 | 170 | $7K |
| 88304 | 260 | 235 | $7K | |
| 73630 | 327 | 276 | $7K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 260 | 218 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 177 | 163 | $7K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 40 | 38 | $6K |
| 73610 | 332 | 284 | $6K | |
| 73030 | 290 | 237 | $6K | |
| 72141 | 31 | 24 | $6K | |
| 83605 | 790 | 622 | $6K | |
| T1015 | Clinic visit/encounter, all-inclusive | 494 | 281 | $5K |
| 93458 | 54 | 40 | $5K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 113 | 41 | $5K |
| 82805 | 242 | 193 | $5K | |
| 71020 | 377 | 343 | $5K | |
| 73560 | 274 | 237 | $5K | |
| 93017 | 406 | 330 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 36 | 33 | $4K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3,065 | 2,787 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 978 | 748 | $4K |
| 85379 | 562 | 489 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 392 | 293 | $4K |
| 36416 | 213 | 108 | $4K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 16 | 14 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 89 | 73 | $3K |
| 97597 | 412 | 215 | $3K | |
| 81003 | 1,871 | 1,589 | $3K | |
| 73130 | 120 | 106 | $3K | |
| 59025 | Fetal non-stress test | 20 | 14 | $3K |
| 71010 | 482 | 431 | $3K | |
| 86900 | 1,125 | 913 | $3K | |
| 82607 | 261 | 227 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 39 | 35 | $2K |
| 87205 | 1,056 | 846 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 134 | 110 | $2K |
| 70486 | 14 | 12 | $1K | |
| 97001 | 30 | 25 | $1K | |
| 84702 | 123 | 107 | $1K | |
| 72100 | 63 | 51 | $1K | |
| 74022 | 54 | 48 | $1K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 682 | 581 | $955.84 |
| 82803 | 66 | 53 | $900.53 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 345 | 93 | $887.51 |
| 73110 | 48 | 41 | $883.70 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 45 | 30 | $830.02 |
| 80074 | 75 | 68 | $811.64 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,326 | 1,083 | $775.31 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,275 | 1,076 | $774.57 |
| 36430 | 15 | 12 | $750.00 | |
| J2060 | Injection, lorazepam, 2 mg | 706 | 599 | $711.53 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,796 | 1,447 | $646.37 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 16 | 13 | $644.48 |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 12 | 12 | $619.20 |
| 74010 | 28 | 27 | $611.57 | |
| 73502 | 31 | 24 | $592.78 | |
| 76801 | 17 | 13 | $586.59 | |
| 76775 | 49 | 41 | $565.17 | |
| 77065 | Tomosynthesis, mammo | 12 | 12 | $553.33 |
| 90715 | 42 | 36 | $460.80 | |
| 86922 | 31 | 24 | $454.96 | |
| J2785 | Injection, regadenoson, 0.1 mg | 19 | 13 | $452.40 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 757 | 649 | $436.44 |
| 76642 | 16 | 16 | $399.71 | |
| 85652 | 212 | 184 | $381.30 | |
| 93971 | 15 | 13 | $375.96 | |
| 86920 | 40 | 26 | $340.00 | |
| 84520 | 16 | 14 | $338.80 | |
| 73120 | 13 | 13 | $320.16 | |
| 85018 | 153 | 125 | $318.95 | |
| 71250 | 12 | 12 | $309.94 | |
| 83540 | 54 | 40 | $265.68 | |
| 82274 | 31 | 27 | $242.44 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,093 | 927 | $236.22 |
| 85576 | 15 | 13 | $214.76 | |
| 85014 | 78 | 72 | $202.80 | |
| 86592 | 26 | 24 | $196.20 | |
| 73070 | 14 | 12 | $180.00 | |
| 74000 | 13 | 12 | $180.00 | |
| 94760 | 26 | 14 | $168.00 | |
| 71015 | 12 | 12 | $154.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 223 | 197 | $137.81 |
| 82565 | 18 | 16 | $131.76 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 161 | 136 | $128.85 |
| J1170 | Injection, hydromorphone, up to 4 mg | 605 | 467 | $121.43 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 342 | 285 | $121.42 |
| 85007 | 36 | 32 | $108.24 | |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 33 | 27 | $107.93 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 265 | 221 | $100.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 1,653 | 1,458 | $54.16 |
| 84436 | 13 | 12 | $44.50 | |
| 86140 | 14 | 12 | $44.34 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 32 | 26 | $39.42 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 230 | 181 | $35.08 |
| J1940 | Injection, furosemide, up to 20 mg | 78 | 51 | $21.29 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 53 | 43 | $14.37 |
| J2704 | Injection, propofol, 10 mg | 283 | 245 | $13.56 |
| J7030 | Infusion, normal saline solution , 1000 cc | 843 | 613 | $1.15 |
| C9113 | Injection, pantoprazole sodium, per vial | 46 | 38 | $0.00 |
| 99152 | 17 | 13 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 15 | 13 | $0.00 |
| P9016 | Red blood cells, leukocytes reduced, each unit | 15 | 12 | $0.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 17 | 12 | $0.00 |